• No results found

Systematic assessment of factors affecting the delivery, access and use of interventions to control malaria in pregnancy in sub-Saharan Africa - Chapter 3: Supplementary appendix

N/A
N/A
Protected

Academic year: 2021

Share "Systematic assessment of factors affecting the delivery, access and use of interventions to control malaria in pregnancy in sub-Saharan Africa - Chapter 3: Supplementary appendix"

Copied!
37
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

UvA-DARE is a service provided by the library of the University of Amsterdam (http

s

://dare.uva.nl)

UvA-DARE (Digital Academic Repository)

Systematic assessment of factors affecting the delivery, access and use of

interventions to control malaria in pregnancy in sub-Saharan Africa

Hill, J.A.

Publication date

2014

Document Version

Final published version

Link to publication

Citation for published version (APA):

Hill, J. A. (2014). Systematic assessment of factors affecting the delivery, access and use of

interventions to control malaria in pregnancy in sub-Saharan Africa. Dutch University Press.

General rights

It is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s)

and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open

content license (like Creative Commons).

Disclaimer/Complaints regulations

If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please

let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material

inaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letter

to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You

will be contacted as soon as possible.

(2)

Chapter 3: Supplementary Appendix

(3)

Coverage of intermittent preventive treatment and insecticide-treated nets for the control of malaria

during pregnancy in sub-Saharan Africa: a synthesis and meta-analysis of national survey data,

2009-11

Table of Contents

1.

eSupplement 1

: Data sources to estimate number of births protected against malaria by

insecticide-treated nets or intermittent preventive treatment in sub-Saharan Africa for 2010

1.1.

eFigure 1

: Flow diagram on data sources to estimate number of births protected against malaria by

insecticide-treated nets or intermittent preventive treatment in sub-Saharan Africa for a hypothetical population in 2010,

and to estimate disbursement of funds for malaria control by external organizations per capita malaria exposed

persons per year per country in 2001-10

2.

eSupplement 2

: Correlation between insecticide-treated net use among women aged 15-49 years

and pregnant women

2.1.

eFigure 2

: Scatterplot of use of insecticide-treated net use among women aged 15-49 years versus pregnant

women in 56 national surveys in 32 sub-Saharan countries in 2001-11

3.

eSupplement 3

: Adjustment of confidence intervals for clustering

3.1.

eTable 3.1: Difference in standard error when adjusted for clustering for prevalence of coverage of intermittent

preventive treatment, insecticide-treated nets and antenatal clinic visits in pregnancy

3.2.

eTable 3.2: Difference in standard error when adjusted for clustering for risk ratios of socio-economic status,

education and location of residence when evaluating effect on intermittent preventive treatment or

insecticide-treated net use in pregnancy

4.

eSupplement 4

: Flow diagram for inclusion and exclusion of surveys

4.1.

eFigure 4

: Flow diagram for inclusion and exclusion of surveys for the review of coverage of malaria prevention

in pregnancy in sub-Saharan Africa, 2009-11

5.

eSupplement 5

: Use of malaria prevention in pregnancy in sub-Saharan Africa as reported in

national surveys, 2005-11

5.1.

eTable 5.1: Coverage of intermittent preventive treatment during pregnancy in sub-Saharan Africa as reported

in national surveys, 2005-11

5.2.

eTable 5.2

: Use of insecticide-treated nets during pregnancy in sub-Saharan Africa as reported in national

surveys, 2005-2011

6.

eSupplement 6

: Calculations of number of births covered by intermittent preventive treatment,

insecticide treated nets and antenatal care in 2010, sub-Saharan Africa

6.1.

eTable 6.1: Calculation of number of births protected by intermittent preventive treatment in sub-Saharan

Africa, projected for 2010

6.2.

eTable 6.2: Calculation of number of births covered by insecticide-treated nets and antenatal care in sub-Saharan

Africa, projected for 2010

6.3.

eTable 6.3: Calculation of number of births covered by at least one or two antenatal care visits in countries with

an intermittent preventive treatment policy, sub-Saharan Africa, projected for 2010

6.4.

eTable 6.4: Calculation of number of births protected by intermittent preventive treatment or insecticide-treated

nets in sub-Saharan Africa, projected for 2007 for countries with a survey in 2004-09 and 2009-11

7.

eSupplement 7

: Information on intermittent preventive treatment or insecticide-treated net use

from sub-Saharan countries with one or two surveys in 2000-11

7.1.

Figure 7.1

: Trends in intermittent preventive treatment coverage in pregnancy among fourteen sub-Saharan

countries with national information in 3 or more surveys

7.2.

eFigure 7.2

: Trends in twenty sub-Saharan countries with national information on intermittent preventive

treatment in pregnancy limited to 1 or 2 surveys

7.3.

eFigure 7.3

:

Meta-analysis of difference in intermittent preventive treatment coverage for 24 countries with >1

survey, Africa, 2000-11

7.4.

eFigure 7.4

: Trends in insecticide-treated net use in pregnancy among thirteen sub-Saharan countries with

national information in 3 or more surveys

7.5.

eFigure 7.5

: Trends in twenty-nine sub-Saharan countries with national information on insecticide-treated net

use in pregnancy limited to 1 or 2 surveys

(4)

7.6.

eFigure 7.6

: Meta-analysis of difference in coverage of insecticide-treated net use for 30 countries with >1 survey,

Africa, 2000-11

8.

eSupplement 8

: Forestplots for effect of socioeconomic, educational status, location of residence,

parity and age on intermittent preventive treatment coverage and insecticide-treated net use for

countries with surveys in 2009-11 and a data set available

8.1.

eFigure 8.1

: Effect of socioeconomic status on intermittent preventive treatment coverage, comparing highest two

wealth quintiles with lower 3 wealth quintiles, among sub-Saharan countries with surveys in 2009-11, random

effects analysis

8.2.

eFigure 8.2

: Effect of education on intermittent preventive treatment coverage, comparing any vs. no education,

among sub-Saharan countries with surveys in 2009-11, random effects analysis

8.3.

eFigure 8.3

: Effect of location of residence on intermittent preventive treatment coverage, comparing urban vs.

rural, among sub-Saharan countries with surveys in 2009-11, random effects analysis

8.4.

eFigure 8.4

: Effect of parity on intermittent preventive treatment coverage, comparing primiparae vs.

multiparae, among sub-Saharan countries with surveys in 2009-11, random effects analysis

8.5.

eFigure 8.5

: Effect of age on intermittent preventive treatment coverage, comparing less than 21 years vs. 21

years or older, among sub-Saharan countries with surveys in 2009-11, random effects analysis

8.6.

eFigure 8.6

: Effect of socioeconomic status on insecticide-treated net use in the previous night among pregnant

women, comparing highest two wealth quintiles vs. lower 3 wealth quintiles, among sub-Saharan countries with

surveys in 2009-11, random effects analysis

8.7.

eFigure 8.7

: Effect of education on insecticide-treated net use in the previous night among pregnant women,

comparing any education vs. none, among sub-Saharan countries with surveys in 2009-11, random effects

meta-analysis

8.8.

eFigure 8.8

: Effect of location of residence on insecticide-treated net use in the previous night among pregnant

women, comparing urban vs. rural residence, among sub-Saharan countries with surveys in 2009-11, random

effects analysis

8.9.

eFigure 8.9

: Effect of gravidity on insecticide-treated net use in the previous night among pregnant women,

comparing primigravidae vs. multigravidae, among sub-Saharan countries with surveys in 2009-11, random

effects analysis

8.10. eFigure 8.10

: Effect of age on insecticide-treated net use in the previous night among pregnant women,

comparing less than 21 years vs. 21 years or older, among sub-Saharan countries with surveys in 2009-11,

random effects analysis

9.

References

(5)

eSupplement 1: Data sources to estimate number of births protected against malaria by

insecticide-treated nets or intermittent preventive treatment in sub-Saharan Africa for

2010

eFigure 1: Flow diagram on data sources to estimate number of births protected against malaria by

insecticide-treated net (ITN) use or intermittent preventive treatment (IPTp) in sub-Saharan Africa for a

hypothetical population in 2010, and to estimate disbursement of funds for malaria control by external

organizations per capita malaria exposed persons per year per country in 2001-10

References

:

1-7

National surveys sub-Saharan Africa:

Demographic and Health surveys1

Malaria Indicator Surveys2

Multiple Indicator Cluster Surveys3

-United Nations Population Division 2010 revised database4

-Dellicour et al 20105

-Gething et al 20106

Coverage IPTp, SP, and ITNs 2009-2011 by country

Organisation for Economic Co-operation and Development7

Disbursement of money for malaria control to sub-Saharan countries from international programmes and agencies in 2001-2010

Projected for 2010:

Number of malaria exposed births covered by IPTp and ITNs in sub-Saharan Africa

Disbursement of money for malaria control by external organizations per

capita malaria exposed persons per year per country (2001-2010)

-United Nations Population Division 2010 revised database4

-Gething et al 20106

Malaria exposed live and stillbirths by country for 2010

Malaria exposed population size 2001-2010 by country

Sources

Intermediate step

Outcome

(6)

eSupplement 2: Correlation between insecticide-treated net use among women aged

15-49 years and pregnant women

eFigure 2: Scatterplot of use of insecticide-treated nets (ITNs) among women aged 15-49 years versus

pregnant women in 56 national surveys in 32 sub-Saharan countries in 2001-11

Using national data from 56 surveys in 32 sub-Saharan countries between 2001 and 2011, we derived a linear

regression model which was used to estimate the ITN use in Mali, Somalia and Swaziland among pregnant

women. Using the formula in eFigure 2.1, the ITN use of 62.7% in Mali among women aged 15-49

corresponded to 66.8% among pregnant women; for Somalia the percentages were 20.9% and 23.1%,

respectively, and for Swaziland they were 3.8% and 5.2%.

y = 1.0454x + 1.269

R² = 0.9633

0

20

40

60

80

100

0

20

40

60

80

100

P

e

rcentag

e

IT

N

use among

preg

nant

women

Percentage ITN use among women aged 15-49 years

Linear Trendline

(7)

eSupplement 3: Adjustment of standard errors of prevalence and risk ratios for

clustering

eTable 3.1: Difference in standard error when adjusted for clustering for prevalence of coverage of IPT,

ITN and ANC in pregnancy

Prevalence

coverage No of surveys Median difference in standard error (IQR)

IPTp 33 0.0030 (0.0010-0.0050) ITN 41 0.0020 (0.0010-0.0040) ANC 1+ 45 0.0040 (0.0020-0.0103) ANC 2+ 35 0.0037 (0.0024-0.0100)

ANC: Antenatal clinic. IPT: intermittent preventive treatment. IQR: interquartile range. ITN: insecticide treated

nets.

Note: All national surveys that were used have in common that they use a cluster design. If this would not be

taken into account, the confidence intervals could be too narrow, because it would be assumed that each

person’s information is independent of each other, whereas information from persons in the same cluster may

have common factors. For surveys with a data set available the difference in standard error was calculated as the

difference in standard error from a model where simple random sampling was assumed and a model where

clustering was taken into account, and the median difference is presented in the table. For survey reports where

no data set was available, we calculated the standard error from the information available in the report, and

added the median difference in standard error as an estimate to take clustering into account. E.g. for Benin, the

proportion of women using IPTp was 0.228 (or 22.8%), and the sample size was 5130; the 95% confidence

interval was 0.2166 to 0.2398, and from this the standard error can be calculated (difference in 95% confidence

interval divided by 2*1.96) as 0.0059. Adding 0.003 for clustering, the adjusted standard error was 0.0089, and

the revised 95% confidence interval was 0.2104 to 0.2456 (or 21.0- 24.6%).

eTable 3.2: Difference in standard error when adjusted for clustering for risk ratio estimates of the effect

of socio-economic status, education and location of residence on IPTp or ITN use in pregnancy

Endpoint Risk ratios evaluated* No of surveys Median difference in standard error (IQR)

IPTp SES 35 0.0190 (0.0043-0.0272) IPTp Education 35 0.0073 (0.0004-0.0172) IPTp Residence 35 0.0261 (0.0094-0.0605) ITN SES 38 0.0112 (0.0005-0.0225) ITN Education 36 0.0051 (0.0000-0.0132) ITN Residence 38 0.0188 (0.0027-0.0372)

IPTp: intermittent preventive treatment in pregnancy. IQR: interquartile range. ITN: insecticide treated nets.

SES: socioeconomic status.

*SES: comparing two highest vs. three lower wealth quintiles; Education: comparing any vs. no education;

Residence: comparing urban vs. rural location of residence

Note: For surveys with a data set available the difference in standard error was calculated as the difference in

standard error from a model where simple random sampling was assumed and a model where clustering was

taken into account, and the median of these differences is presented in the table. Note that the standard error is

calculated for the natural log of the risk ratio, and the 95% CI is the natural log of the RR ± (1.96*standard

error). To convert the limits to a non-logarithmic scale, the antilogs of these limits are taken. E.g. for Chad, the

risk ratio for IPTp for SES was 2.815 and the 95% CI 2.387-3.320; the natural logs for the limits are 0.8700 and

1.200 respectively, and the standard error can be calculated as 0.0842. The correction for clustering of 0.0190 is

added (the adjusted standard error becomes 0.1032), so the natural logs of the confidence interval change into

0.8328 and 1.2372, and when these are converted using antilogs, the 95% confidence interval changes into

2.2997 to 3.446 (or 2.30-3.45 when rounded).

(8)

eSupplem

en

t 4

: F

low di

agr

am

for

inc

lusion an

d e

xc

lusion o

f sur

ve

ys

eF

igur

e 4

: Flow

d

iagram

for in

clu

sion

and

ex

cl

u

sion

of su

rveys

for th

e revie

w

o

f cove

rage of

m

alaria p

reven

tion

in

p

regn

an

cy in

s

u

b-S

ah

aran

Afri

ca, 20

09-11

38

c

o

untrie

s I

P

Tp p

o

licy

Screening

Included

Eligibility

Identification

45

co

untri

es ITN p

o

licy fo

r

pre

gnant

wo

me

n

45

m

alari

o

u

s c

o

untrie

s in s

u

b-Saharan Africa

No

te

: Tanzania and Zanzib

ar co

nside

re

d

as

se

parat

e

c

o

untrie

s

-2

ex

cluded, l

o

w

m

alaria

ris

k, no

M

iP

po

licie

s: S

o

uth Africa

and

Cape

Ve

rde

-5

e

xclude

d, no IPTp po

lic

y:

Burundi, D

jibo

u

ti,

Eritre

a,

Ethio

p

ia and S

w

aziland

-2

e

xclude

d, IPTp po

licy

withdrawn: Nam

ibia,

Rwan

da

29

n

ation

al

su

rv

eys

with

IP

Tp

dat

a in 20

09

-11

fr

om

28

co

untries

38

na

tio

n

al sur

ve

ys

with IT

N

dat

a in 20

09

-11

fr

om

37

co

untries

-9

e

xclude

d, sur

ve

y c

o

nducte

d

o

r planne

d but

n

o

dat

a ye

t

av

ailable:

Central

African

Republic, Como

ro

s, Gab

o

n,

Ghana, Guinea,

M

ali,

M

auritania, Niger,

Som

alia

-4

e

xclude

d, sur

ve

y

co

nducte

d

o

r planne

d but

no

data

ye

t available

:

Com

o

ro

s, Ghana,

Guinea,

M

auritania

-3

e

xclude

d, no surve

y

planne

d:

Botswana,

Eritr

e

a,

Sao

T

o

m

e

& P

rinci

p

e

27

natio

n

al

surve

ys

include

d

fro

m

27

c

o

unt

rie

s

-1

e

xclude

d, be

caus

e

t

w

o

national sur

ve

ys in

one

yea

r:

MI

S Mal

awi

20

10

-1

e

xclude

d, stud

y po

pulati

o

n

included pregnant w

o

men

still

takin

g IP

Tp

: M

IS Sudan 20

09

37

na

tio

n

al sur

ve

ys include

d

fro

m

37

c

o

unt

rie

s

-1

e

xclude

d, be

caus

e

t

w

o

natio

n

al sur

ve

ys in

one

yea

r:

MI

S Mal

awi

20

10

2

10

(9)

IPT

p: in

term

itten

t prev

en

ti

ve t

reat

m

ent. IT

N: in

secticide-tre

ate

d n

ets

. MiP

: m

alaria i

n preg

na

nc

y. MI

S: Malaria In

dicat

or Su

rv

ey.

Note: In

clusion

criteria: Malar

iou

s coun

tries i

n s

ub-Sah

ara

n Af

rica

w

ith

eit

he

r IPT

p or I

T

N policy

fo

r preg

na

nt

w

om

en

an

d n

atio

na

l su

rv

ey

w

ith

cov

erag

e data f

or IP

T

p, or

IT

N u

se in

th

e ti

m

e period 20

09-11. F

or

IP

Tp, th

e s

tu

dy

popu

lation

sh

ould n

ot in

cl

ud

e preg

na

nt

w

om

en

. If

m

ore th

an

on

e su

rv

ey

w

as

con

du

cte

d i

n 2

009-11,

on

ly

th

e l

as

t

sur

ve

y w

as u

se

d.

2

11

(10)

eS

u

pplem

ent 5

: Use of

m

alaria pr

evention in p

regnancy in sub-Sahara

n Af

rica as reported in national surveys, 2005-11

eTable 5.

1: Cov

erage

of in

te

rm

itten

t p

reven

tive treatm

en

t in

s

u

b

-S

ah

aran

Africa as

rep

orted

in

n

ation

al s

u

rveys

, 2005

-11

Co untr y P oli cy Ado pte d* Sur ve y i n 2 005 -08 Sur ve y i n 2 009 -11 R ef eren ce Sa m pl e si ze SP , an y, % IPT p 2 + ANC % IPT p2 + ANC vi sitor s, % R efe ren ce or ex pect ed s urv ey Sa m pl e Si ze SP , an y, % IPT p 2 + , ANC, % IPT p2 + ANC vi sitor s IPT p 2 + Any so ur ce Ang ol a IP T p2 20 05 MI CS 200 8-9 N R N R 16 .4 24 .3 MI S 20 11 30 94 30 .1 17 .5 ¦ 18 .6 Ben in IP T p2 2005 DHS 2 006 6380 4. 9 3. 0‡ ¦ D H Sp 2 011-12 5130 NYA 22 .8 26 .6 NYA Bot sw an a No I P T p Bu rk in a Fas o IP T p2 2005 MI CS 200 6 2370 1. 8 1. 3‡ ¦ DHS 2 010 -11 5988 73 .8 10 .6 11 .2 20 .8 B ur undi No I P T p C am eroon IP T p2† 2004 MI CS 200 6 2834 9. 7 5. 8 7. 9 D H Sp 2 011 4075 NYA 25 .6 30 .2 26 .7 C en tra l A fri can Re publ ic IP T p2 20 04 MI CS 200 6 40 85 12 .0 8. 7‡ ¦ MI CS 201 0 N Y A Cha d IP T p2 2004 No d ata MI CS 201 0 6217 10 .8 9. 3 21 .9 NR Co m or os IP T p2 2003 No d ata DHS 2 012 NYA C on go ( B ra zz av ille) IP T p2 2006 DHS 2 005 3568 2. 0 NR D H Sp 2 011-12 3426 NYA 22 .2 24 .0 NYA te d'Ivo ir e IP T p2 20 05 MI CS 200 6 35 86 12 .0 8. 3‡ ¦ D H Sp 2 012 30 39 N Y A 17 .6 19 .4 N Y A Dji bo uti No I P T p DR Co ngo IP T p2 20 04 D H S 20 07 34 35 16 .2 5. 1 6. 0 MI CS 201 0 50 36 34 .3 18 .1 20 .7 N R Eq ua to ri al G uin ea IP T p2 2005 MI S 20 08 83 8 40 .7 21 .4 ‡ ¦ MI S 20 09 74 5 48 .7 29 .8 ‡ ¦ 29 .8 Erit re a No I P T p M IS 20 08 NYA Et hi op ia No I P T p Ga bo n IP T p2 2003 No d ata DHS 2 012 NYA Ga m bi a IP T p2 2003 MI S 20 08 97 9 99 .6 48 .9 ¦ MI CS 201 0 4963 94 .8 64 .9 66 .2 NR Gha na IP T p3 20 03 D H S 20 08 11 78 58 .2 43 .7 47 .4 MI CS 201 1 N Y A Gui ne a IP T p2 2005 DHS 2 005 4447 4. 5 2. 9 3. 5 DHS 2 012 NYA G uin ea -Bis sa u IP T p2 20 04 MI CS 200 6 25 06 10 .3 7. 4‡ ¦ MI CS p 20 10 N Y A N Y A 14 .2 15 .3 N R Ke nya IP T p2† 1999 DHS 2 008 -9 2264 35 .5 14 .0 15 .3 MI S 20 10 1509 46 .9 25 .4 29 .6 25 .7 Lib eri a IP T p2 20 04 MI S 20 08-9 15 73 57 .9 45 .1 47 .3 MI S 20 11 12 30 63 .2 49 .6 ¦ 50 .3 Ma daga sc ar IP T p2 2004 DHS 2 008 -9 4807 11 .8 6. 4 7. 4 MI S 20 11* * 2477 31 .6 19 .5 ¦ 19 .5 Ma law i IP T p2† 19 93 MI CS 200 6 10 55 2 80 .7 46 .7 ‡ ¦ D H S 20 10 77 24 87 .6 53 .8 56 .8 55 .0 Ma li IP T p2 2003 DHS 2 006 5663 16 .1 4. 0 5. 7 MI CS 200 9-10 NYA Ma ur ita nia IP T p2 20 06 N o dat a MI CS 201 1 N Y A Mo za m bi que IP T p3 2006 MI CS 200 8 5191 56 .9 43 .1 ‡ ¦ D H Sp 2 011 4193 NYA 18 .6 20 .5 NYA Na m ibi a IP T p2 20 05 -2 01 0 D H S 20 06 -7 20 54 27 .8 10 .0 10 .6 MI S 20 09* * 19 2 8. 3§ 4. 9§ ¦ Ni ge r IP T p2 2005 DHS 2 006 6301 <1 <1 ¦ DHS 2 012 NYA Ni ge ria IP T p2 20 04 D H S 20 08 11 02 7 10 .9 4. 9 8. 5 MI S 20 10 22 55 20 .2 13 .2 23 .0 17 .4 Rw an da IP T p2 2005 -20 08 DHS 2 007 -8 2267 53 .0 17 .2 18 .0 Sa o To m e & P . IP T p2 20 04 MI CS 200 6 N R D H S 20 08 -9 73 3 88 .1 59 .8 61 .0 61 .6 Se ne ga l IP T p2 2004 MI S 20 08-9 5406 78 .1 52 .2 ¦ DHS 2 010 -11 4509 68 .2 38 .6 41 .4 40 .1 Si er ra L eo ne IP T p2 20 04 D H S 20 08 24 78 19 .5 10 .3 11 .9 MI CS 201 0 34 62 53 .0 38 .5 41 .4 N R So m alia IP T p2 2002 MI CS 200 6 2325 2. 2 0. 9‡ ¦ MI CS 201 1 NYA So uth Suda n IP T p2 20 05 N o dat a MI S 20 09 99 7 21 .6 12 .7 23 .1 19 .6 Suda n IP T p2 2005 MI S 20 05 95 2 3. 6 1. 8 2. 5 MI S 20 09 1966 2. 5§ 0. 6§ ¦

2

12

(11)

Co untr y P oli cy Ado pte d* Sur ve y i n 2 005 -08 Sur ve y i n 2 009 -11 Sw az il an d No I P T p Tan zan ia , m ain la nd IP T p2 2001 MI S 20 07-8 2967 58 .4 29 .6 30 .5 DHS 2 009 -10 3179 62 .7 25 .7 26 .8 26 .7 To go IP T p2 20 03 MI CS 200 6 16 27 23 .2 18 .1 ‡ ¦ MI CS 201 0 17 92 52 .4 35 .9 50 .1 N R U gan da IP T p2 2000 DHS 2 006 3247 36 .6 16 .2 17 .3 DHS 2 011 3092 48 .4 24 .5 25 .8 26 .7 Za m bi a IP T p3 20 01 MI S 20 08 23 91 80 .0 60 .3 ¦ MI S 20 10 24 35 85 .8 69 .4 ¦ 70 .2 Za nz ib ar IP T p2 2001 MI S 20 07-8 77 78 .4 51 .5 53 .8 DHS 2 009 -10 87 84 .1 47 .0 47 .0 47 .3 Zi m ba bw e IP T p3 20 04 D H S 20 05 -6 21 44 12 .1 6. 3 6. 7 D H S 20 10 -1 1 24 48 13 .9 7. 3 8. 3 7. 8

A

N

C: a

nten

atal cli

nic. DHS:

De

m

og

rap

hic an

d Healt

h S

urv

ey

. DHSp

: p

reli

m

in

ar

y re

su

lt

s

of

DHS.

IP

Tp

2: in

ter

m

itte

nt p

rev

en

ti

ve

tre

at

m

ent u

sing

2 dos

es

of

S

P

. IP

T

p3: in

term

itten

t prev

en

tiv

e

treat

m

en

t using

3 dos

es of

SP

. IPT

p 2+, A

N

C: inter

m

itten

t p

rev

en

tiv

e treat

m

ent

w

ith

at lea

st 2 doses of

SP

, of

w

hic

h at least o

ne

f

ro

m

th

e

A

N

C. MICS

: Mu

ltiple In

dicator Cl

us

ter Surv

ey

.

MIC

S

p; preli

m

in

ar

y resu

lt

s of MIC

S

. MIS

: Malaria In

dicat

or S

urv

ey

. MIS

p: preli

m

in

ar

y res

ult

s of

MIS

. NR

: Not report

ed. NYA

: s

ur

ve

y d

ata n

ot

ye

t av

ailab

le. SP

: su

lfad

ox

in

e-py

rim

eth

am

in

e.

*B

es

t esti

m

ate o

n p

olic

y ad

op

tio

n d

ate f

ro

m

a

vailab

le reso

ur

ces

8

†A

lt

hough

n

o f

or

m

al

3-dos

e SP policy

h

as

bee

n adopted, an

ten

atal s

ta

ff i

n Mala

w

i an

d Ke

ny

a are en

co

ur

ag

ed to g

iv

e S

P

at ev

er

y a

nten

atal

visit

w

hich

is at least o

ne

m

on

th

ap

art f

ro

m

th

e

prev

iou

s dos

e. C

am

eroon

m

ay h

av

e s

w

itc

he

d to IP

Tp3+.

‡Any

S

P

or IP

T

p2+ f

rom

a

ny

so

ur

ce, n

ot j

us

t A

N

C

§

T

he

M

IS in N

amib

ia

u

se

d p

re

gna

nt

w

ome

n a

s sa

m

ple

a

nd

no

t w

ome

n

w

ith

a

b

irt

h in t

he

la

st 2

o

r 5

y

ea

rs a

s is t

he

us

ua

l sa

m

ple

fo

r t

he oth

er su

rv

ey

s.

T

he MIS

in

S

udan

u

sed pregnan

t w

om

en

or w

om

en

w

ith

a birth

in

th

e pas

t y

ear.

¶ IPTp w

ith

at lea

st t

w

o dos

es

of

S

P

of

w

hic

h at leas

t on

e

from

th

e

ANC

a

s percen

tag

e a

m

on

g e

sti

m

ated num

ber of

A

N

C

atten

dees

, usi

ng

th

e reported p

ercen

tag

e

A

N

C atte

nd

an

ce (at

least on

e

visi

t) in

th

e sa

m

e rep

or

t.

¦N

ot en

ou

gh

in

fo

rm

ation

a

vail

able to calcu

late cov

erag

e of

2

+ dos

es

of

SP

of

w

hic

h at leas

t on

e f

ro

m

th

e

A

N

C

a

m

on

g ANC

–atten

dee

s.

**S

ur

ve

y c

ond

uc

te

d i

n a

re

as a

t m

ala

ria

r

isk o

nl

y i

n t

he

c

ou

nt

ry

(12)

eTabl

e 5.

2:

Us

e of in

se

cticid

e-treated

n

ets

d

u

rin

g p

regn

an

cy in

s

u

b

-S

ah

aran

Africa as

rep

orted

in

n

ation

al s

u

rveys

,

2005-11

Co untr y Ado pte d* Sur ve y i n 2 005 -08 Sur ve y i n 2 009 -11 Inse cti cid e r esi du al sp ra yi ng (IRS) Re fe re nc e Sa m pl e si ze IT N, % R efe ren ce or ex pect ed s urv ey Sa m pl e Si ze IT N, % IRS a nd/o r IT N, % IR S rec om m en ded (y ea r ad op te d)9 IRS sa m pl e si ze (ho use hol ds) IRS ho use ho lds, % (sur ve y 20 09 -11 ) Ang ol a 20 00 MI CS 200 8-9 N R 18 .4 MI S 20 11 13 84 25 .6 N R Y es ( 200 3) 80 30 7. 0 Ben in 2002 DHS 2 006 1962 19 .6 D H Sp 2 011-12 1560 75 .5 NR Y es ( 200 6) No I R S re po rt ed Bot sw an a 20 06 N o dat a N o dat a Y es ( 195 0) Bu rk in a Fas o 2004 No d ata DHS 2 010 1738 44 .6 44 .9 Y es ( 200 6) 1442 4 0. 9 B ur undi 20 02 N o dat a D H S 20 10 -1 1 96 2 49 .9 49 .9 Y es ( 200 9) 85 96 0. 3 C am eroon 2003 No d ata D H Sp 2 011 78 2 19 .8 20 .8 Y es ( 200 7) 7133 2. 6 C en tra l A fri can R ep . 2006 No d ata M IC S 2 01 0 NYA No Cha d 2003 No d ata MI CS 201 0 2273 9. 9 NR Yes (NR ) No I R S re po rt ed Co m or os 2001 No d ata DHS 2 012 NYA Yes (NR ) C on go ( B ra zz av ille) 2004 DHS 2 005 66 5 4. 2 D H Sp 2 011-12 1123 20 .7 NR Yes (NR ) No I R S re po rt ed te d'Ivo ir e 20 05 N o dat a D H Sp 2 011-20 12 11 21 39 .9 41 .2 N o 10 22 6 1. 4 Dji bo uti 2000 MI S 20 08-9 16 3 25 .2 MI CS 201 1 NYA Y es ( 200 6) 50 5 14 .0 DR Co ngo 20 06 D H S 20 07 11 50 7. 1 MI CS 201 0 16 13 42 .6 N R Y es ( 200 7) N o I R S r epo rte d Eq ua to ri al G uin ea 2007 MI S 20 08 52 1 50 .9 MI S 20 09 42 4 35 .3 NR Y es ( 200 5) 3162 55 .0 Erit re a 20 02 MI S 20 08 N Y A N o dat a Y es ( 199 5) Et hi op ia 2001 MI S 20 07 56 8 35 .2 MI S 20 11 ‡ 39 0 34 .7 NR Y es ( 196 0) 1044 4 29 .2 Ga bo n 2003 ONS 2 008 86 0 36 .2 DHS 2 011 NYA No Ga m bi a 2002 MI S 20 08 40 2 45 .0 MI CS 201 0 1545 26 .1 NR Y es ( 200 8) No I R S re po rt ed Gha na 19 99 D H S 20 08 35 3 19 .9 MI CS 201 1 N Y A Y es ( 200 5) Gui ne a 2002 ONS 2 007 -8 2141 3. 2 DHS 2 012 NYA No G uin ea -Bis sa u 2004 No d ata M IC Sp 2 010 NYA 31 .7 NYA Yes (2 00 6) NYA Ke nya 2001 DHS 2 008 -9 60 1 49 .0 MI S 20 10 39 8 41 .1 48 .5 Y es ( 200 3) 6538 10 .8 Lib eri a 20 04 MI S 20 08-9 47 1 32 .9 MI S 20 11 36 3 39 .0 45 .4 Y es ( 200 9) 41 62 8. 6 Ma daga sc ar 2000 DHS 2 008 -9 1425 46 .2 MI S 20 11 ‡ 65 7 71 .5 85 .6 Y es ( 199 3) 8049 40 .7 Ma law i 20 02 MI CS 200 6 10 55 2 25 .6 † D H S 20 10 20 86 35 .2 36 .2 Y es ( 200 7) 24 82 5 2. 2 Ma li 2006 DHS 2 006 1896 28 .9 MI S 20 10 2191 62 .7 † NR Y es ( 200 7) 1617 5. 1 Ma ur ita nia 2002 No d ata M IC S 2 01 1 NYA No Mo za m bi que 2003 MI S 20 07 58 9 7. 3 D H Sp 2 011 1450 19 .5 33 .5 Y es ( 200 3) 1391 9 18 .5 Na m ibi a 20 02 D H S 20 06 -7 54 1 8. 8 MI S 20 09 ‡ 19 4 25 .9 N R Y es ( 196 5) 28 23 21 .7 Ni ge r 1998 DHS 2 006 1311 6. 7 ONS 2 010 NR 71 .5 NR Y es ( 200 3) No I R S re po rt ed Ni ge ria 20 01 D H S 20 08 33 97 4. 8 MI S 20 10 75 2 33 .6 34 .0 Y es ( 200 7) 58 95 0. 7 Rw an da 2000 DHS 2 007 -8 67 3 60 .3 DHS 2 010 -11 95 2 72 .2 NR Y es ( 200 9) No I R S re po rt ed Sa o To m e & P rin cipe 20 04 D H S 20 08 -9 23 7 56 .7 N o dat a Y es ( 200 3) Se ne ga l 1998 MI S 20 08-9 2949 28 .5 DHS 2 010 -11 1279 36 .0 43 .1 Y es ( 200 5) 7902 9. 1 Si er ra L eo ne 20 00 D H S 20 08 61 5 27 .2 MI CS 201 0 14 31 26 .6 N R Y es ( 201 0) N o I R S r epo rte d So m alia 2002 FS NA U 20 08-9 1060 1 20 .9 † MI CS 201 1 NYA Y es ( 200 4) So uth Suda n 20 04 N o dat a MI S 20 09 52 4 29 .3 N R N o 25 45 2. 4 Suda n 2001 MI S 20 05 33 0 12 .7 MI S 20 09 64 3 17 .2 NR Y es ( 195 6) No I R S re po rt ed Sw az il an d 20 02 D H S 20 06 -7 29 6 0. 9 MI S 20 10 ‡ 12 96 3. 8† N R Y es ( 194 7) 17 51 44 .5 Tan zan ia , m ain la nd 2004 MI S 20 07-8 82 3 26 .0 DHS 2 009 -10 92 2 57 .1 NR Y es ( 200 6) No I R S re po rt ed To go 20 01 N o dat a MI CS 201 0 47 0 46 .3 N R Y es ( 201 1) N o I R S r epo rte d U gan da 2003 DHS 2 006 1019 10 .0 DHS 2 011 1009 46 .9 49 .8 Y es ( 200 5) 9033 7. 2 Za m bi a 20 00 MI S 20 08 41 6 43 .2 MI S 20 10 34 2 45 .9 N R Y es ( N R) 43 61 23 .1 Za nz ib ar 2004 MI S 20 07-8 23 51 .3 DHS 2 009 -10 25 49 .5 NR Y es ( 200 6) No I R S re po rt ed

2

14

(13)

Zi m ba bw e 20 01 MI S 20 08 23 8 5. 6 D H S 20 10 -1 1 76 4 9. 6 23 .2 Y es ( 194 8) 97 56 17 .0

DHS: De

m

og

raph

ic a

nd Healt

h S

urv

ey

. D

H

Sp: preli

m

in

ar

y res

ult

s of

DHS. MI

C

S

: M

ultip

le In

dicator C

lu

ster Su

rv

ey

. F

S

N

A

U: Food Secu

rit

y an

d N

utrition

Unit-So

m

al

ia. IRS: In

door

R

es

id

ual Spra

yin

g. IT

N: In

sec

ticide treated n

et. MIC

S

p: preli

m

in

ar

y res

ult

s of

MIC

S

. MIS

: Malaria In

dicator Su

rv

ey

. M

ISp: prel

im

in

ar

y re

su

lts o

f MI

S. NR: No

t rep

or

ted

. NYA

: s

urv

ey

d

ata

no

t y

et a

vailab

le. ONS: Ot

he

r Natio

na

l S

urv

ey

.

*

B

est esti

m

ate o

n p

olic

y ad

op

tio

n d

ate f

or p

reg

nan

t w

om

en

as targ

et

gr

ou

p f

or IT

Ns

f

rom

av

ai

lable res

ou

rces

8

†S

tu

dy

popu

la

tio

n i

s n

on-pregn

an

t w

om

en

; n

o i

nf

or

m

at

io

n for preg

na

nt

w

om

en

av

ail

abl

e i

n t

he

se su

rv

ey

s.

‡Madag

as

car: 3 n

on-m

alaria

l dis

tricts

(

A

nta

na

nariv

o R

en

ivoh

itra, An

tsirabe I, F

ian

aran

tsoa) an

d com

m

un

iti

es

> 1500

m

eter abov

e

sea lev

el ex

cl

ud

ed

f

ro

m

s

ur

ve

y; Eth

iopia: on

ly

areas

in

cl

ud

ed

w

ith

altit

ud

e <2000

m

eter. Na

m

ibia an

d S

w

azila

nd: s

urv

ey

con

du

cted i

n areas

a

t m

alaria ris

k.

2

15

(14)

eS

u

pplem

ent 6

: C

alc

ula

tions o

f n

u

m

be

r o

f bir

ths c

ov

er

ed by int

erm

itte

nt

pr

ev

ent

iv

e t

re

atm

en

t, ins

ec

tic

ide

-tr

ea

te

d ne

ts a

nd a

nt

enat

al c

ar

e in

2010,

sub-Saharan A

frica, 2009-11

eTable 6.

1: Ca

lcula

tio

n o

f nu

m

b

er o

f births pro

tected by

inter

m

ittent

prev

entiv

e trea

tm

en

t in su

b-Sa

ha

ra

n Africa

, pro

jected fo

r

20

10

Co untr y UNDP 2010 10 D ell ic ou r 2 01 05 suppl em ent 2 E sti m ate d nu m be r of liv e an d stillb irt hs Ge thi ng 2010 6 suppl em ent 1 Ma la ri a ex po sed Liv e + s till-bi rths f or 2010 Co un tr ie s wit h IPT p po li cy Co untr ie s wi th IPT p su rv ey 20 09 -1 1 Ma la ri a ex po se d bi rths i n cou nt ries wit h I P Tp po licy , 2010 Ma la ri a ex po sed bi rths f or 2010 in cou nt ries wit h I P Tp su rv ey in 20 09 -1 1 IPT p cov era ge 20 09 -11 ( 2+ do se s) % 95 % CI* , % N u m ber o f ma la ria ex po sed bi rths pr ot ec te d b y IPT p fo r 2010 Lo we r 95% C I bi rths pr ote cte d Uppe r 95% C I bi rths pr ote cte d Liv e b irt hs Liv e bi rths (% ) St illb irt hs (% ) % Po pu la tio n no t m ala ria ex po sed A ng ol a 77 4, 000 75 .1 2. 5 79 9, 766 1. 8 78 5, 370 1 1 78 5, 370 78 5, 370 17 .5 14 .6-20 .4 13 7, 440 11 4, 664 16 0, 215 Be ni n 33 6, 000 73 .9 2. 3 34 6, 45 7 0. 0 34 6, 45 7 1 1 34 6, 45 7 34 6, 45 7 22 .8 21 .0-24 .6 78 ,9 92 72 ,7 56 85 ,2 29 Bo ts w ana 47 ,0 00 68 .3 1. 3 47 ,8 95 46 .8 25 ,4 80 Bur ki na F as o 67 2, 00 0 73 .9 2. 0 69 0, 18 7 0. 0 69 0, 18 7 1 1 69 0, 18 7 69 0, 18 7 10 .6 9. 2-12 .0 73 ,1 60 63 ,4 97 82 ,8 22 Bur un di 26 8, 000 70 .4 2. 5 27 7, 517 29 .3 19 6, 205 Cam ero on 69 1, 000 75 .1 2. 1 71 0, 322 1. 8 69 7, 536 1 1 69 7, 536 69 7, 536 25 .6 23 .8-27 .4 17 8, 569 16 6, 014 19 1, 125 CA R 15 0, 000 75 .1 2. 2 15 4, 394 0. 0 15 4, 394 1 15 4, 394 Ch ad 48 2, 00 0 75 .1 2. 6 49 8, 68 7 0. 0 49 8, 68 7 1 1 49 8, 68 7 49 8, 68 7 9. 3 8. 0-10 .6 46 ,3 78 39 ,8 95 52 ,8 61 Co m or os 27 ,0 00 70 .4 1. 9 27 ,7 29 2. 8 26 ,9 52 1 26 ,9 52 Co ng o 13 6, 000 75 .1 2. 2 13 9, 98 4 0. 0 13 9, 98 4 1 1 13 9, 98 4 13 9, 98 4 22 .2 20 .2-24 .2 31 ,0 76 28 ,2 77 33 ,8 76 Co te d' Ivo ire 66 0, 000 73 .9 2. 6 68 3, 221 0. 0 68 3, 221 1 1 68 3, 221 68 3, 221 17 .6 15 .6-19 .6 12 0, 247 10 6, 582 13 3, 911 D jibo uti 25 ,0 00 70 .4 2. 5 25 ,8 88 34 .8 16 ,8 79 D R C 2, 77 2, 000 75 .1 2. 6 2, 86 7, 968 6. 2 2, 69 0, 154 1 1 2, 69 0, 154 2, 69 0, 154 18 .1 16 .5-19 .7 48 6, 918 44 3, 875 52 9, 960 Eq uato rial G uine a 24 ,0 00 75 .1 2. 0 24 ,6 39 0. 7 24 ,4 67 1 1 24 ,4 67 24 ,4 67 29 .8 25 .9-33 .7 7, 29 1 6, 33 7 8, 24 5 Er itr ea 18 3, 00 0 70 .4 2. 0 18 8, 19 9 11 .3 16 6, 93 2 E th io pia 2, 61 9, 000 70 .4 2. 6 2, 71 5, 724 36 .6 1, 72 1, 769 G abo n 39 ,0 00 75 .1 1. 4 39 ,7 27 0. 0 39 ,7 27 1 39 ,7 27 G am bia 64 ,0 00 73 .9 2. 1 65 ,8 19 0. 0 65 ,8 19 1 1 65 ,8 19 65 ,8 19 64 .9 63 .0-66 .8 42 ,7 16 41 ,4 66 43 ,9 67 G hana 75 1, 000 73 .9 1. 8 76 9, 292 0. 0 76 9, 292 1 76 9, 292 G uine a 38 0, 000 73 .9 2. 2 39 1, 313 0. 0 39 1, 313 1 39 1, 313 G uine a B iss au 57 ,0 00 73 .9 2. 7 59 ,0 83 0. 0 59 ,0 83 1 1 59 ,0 83 59 ,0 83 14 .2 12 .2-16 .2 8, 39 0 7, 20 8 9, 57 1 K eny a 1, 44 7, 000 70 .4 3. 3 1, 51 4, 828 29 .1 1, 07 4, 013 1 1 1, 07 4, 013 1, 07 4, 013 25 .4 22 .7-28 .1 27 2, 799 24 3, 801 30 1, 798 L ibe ria 14 5, 000 73 .9 2. 4 14 9, 70 9 0. 0 14 9, 70 9 1 1 14 9, 70 9 14 9, 70 9 49 .6 45 .9-53 .3 74 ,2 56 68 ,7 16 79 ,7 95 Ma dag as car 69 8, 000 70 .4 2. 1 71 8, 821 9. 7 64 9, 095 1 1 64 9, 095 64 9, 095 19 .5 16 .8-22 .2 12 6, 574 10 9, 048 14 4, 099

21

6

(15)

Co untr y UNDP 2010 10 D ell ic ou r 2 01 05 suppl em ent 2 E sti m ate d nu m be r of liv e an d stillb irt hs Ge thi ng 2010 6 suppl em ent 1 Ma la ri a ex po sed Liv e + s till-bi rths f or 2010 Co un tr ie s wit h IPT p po li cy Co untr ie s wi th IPT p su rv ey 20 09 -1 1 Ma la ri a ex po se d bi rths i n cou nt ries wit h I P Tp po li cy , 2010 Ma la ri a ex po sed bi rths f or 2010 in co untr ie s wit h I P Tp su rv ey in 20 09 -1 1 IPT p cov era ge 20 09 -11 ( 2+ do se s) % 95 % CI* , % N u m ber o f ma la ria ex po se d bi rths pr ot ec te d b y IPT p fo r 2010 Lo we r 95% C I bi rths pr ote cte d Uppe r 95% C I bi rths pr ote cte d Liv e b irt hs Liv e bi rths (% ) St illb irt hs (% ) % Po pu la tio n no t m ala ria ex po sed Mal aw i 61 0, 000 70 .4 2. 9 63 5, 128 0. 0 63 5, 128 1 1 63 5, 128 63 5, 128 53 .8 52 .4-55 .2 34 1, 699 33 2, 807 35 0, 591 Mal i 68 0, 000 73 .9 1. 8 69 6, 563 0. 0 69 6, 563 1 69 6, 563 Ma ur ita nia 11 3, 000 73 .9 2. 3 11 6, 517 5. 0 11 0, 691 1 11 0, 691 Mo za m bi que 86 9, 000 70 .4 2. 3 89 7, 391 0. 1 89 6, 493 1 1 89 6, 493 89 6, 493 18 .6 16 .8-20 .4 16 6, 748 15 0, 611 18 2, 885 N am ibia 60 ,0 00 68 .3 1. 3 61 ,1 42 15 .4 51 ,7 26 N ig er 70 5, 000 73 .9 2. 9 73 2, 666 0. 0 73 2, 666 1 73 2, 666 N ig eri a 6, 02 6, 000 73 .9 2. 3 6, 21 3, 548 0. 0 6, 21 3, 548 1 1 6, 21 3, 548 6, 21 3, 548 13 .2 10 .7-15 .7 82 0, 188 66 4, 850 97 5, 527 Rw and a 40 4, 00 0 70 .4 2. 2 41 6, 62 5 43 .4 23 5, 81 0 Sa o T om e & P . 5, 00 0 75 .1 1. 9 5, 12 6 3. 6 4, 94 2 1 1 4, 94 2 4, 94 2 59 .8 55 .1-64 .5 2, 95 5 2, 72 3 3, 18 8 Se ne ga l 45 0, 000 73 .9 2. 0 46 2, 179 0. 0 46 2, 179 1 1 46 2, 179 46 2, 179 38 .6 36 .2-41 .0 17 8, 401 16 7, 309 18 9, 493 Sie rra L eo na 22 4, 00 0 73 .9 2. 8 23 2, 48 7 0. 0 23 2, 48 7 1 1 23 2, 48 7 23 2, 48 7 38 .5 36 .3-40 .7 89 ,5 08 84 ,3 93 94 ,6 22 So m alia 39 1, 000 70 .4 3. 3 40 9, 328 0. 0 40 9, 205 1 40 9, 205 Sud an ( N or th) 1, 38 4, 981 69 .9 3. 9 1, 46 2, 254 0. 0 1, 46 2, 108 1 1, 46 2, 108 Su da n ( So uth ) 26 8, 69 0 69 .9 3. 9 28 3, 68 1 0. 0 28 3, 65 3 1 1 28 3, 65 3 28 3, 65 3 12 .7 10 .0-15 .4 36 ,0 24 28 ,3 65 43 ,6 83 Sw az iland 34 ,0 00 68 .3 1. 5 34 ,7 47 77 .1 7, 95 7 T anz ani a Ma inl . 1, 74 1, 000 70 .4 2. 1 1, 79 2, 933 3. 8 1, 72 4, 802 1 1 1, 72 4, 802 1, 72 4, 802 25 .7 23 .5-27 .9 44 3, 274 40 5, 328 48 1, 220 T ogo 19 0, 00 0 73 .9 2. 0 19 5, 14 2 0. 0 19 5, 14 2 1 1 19 5, 14 2 19 5, 14 2 35 .9 33 .2-38 .6 70 ,0 56 64 ,7 87 75 ,3 25 U gand a 1, 43 3, 000 70 .4 2. 3 1, 47 9, 817 6. 5 1, 38 3, 629 1 1 1, 38 3, 629 1, 38 3, 629 24 .5 22 .7-26 .3 33 8, 989 31 4, 084 36 3, 894 Z am bia 54 7, 000 70 .4 2. 2 56 4, 094 0. 0 56 4, 094 1 1 56 4, 094 56 4, 094 69 .4 67 .0-71 .8 39 1, 481 37 7, 943 40 5, 019 Z anz ibar 50 ,4 89 70 .4 2. 1 51 ,9 95 0. 0 51 ,9 95 1 1 51 ,9 95 51 ,9 95 47 .0 35 .6-58 .4 24 ,4 38 18 ,5 10 30 ,3 65 Z im ba bw e 37 0, 000 70 .4 1. 6 37 8, 409 44 .5 21 0, 017 1 1 21 0, 017 21 0, 017 7. 3 5. 9-8. 7 15 ,3 31 12 ,3 91 18 ,2 71 Tot als 28 ,6 27 ,5 59 37 27 26 ,2 04 ,8 01 21 ,4 11 ,8 90 21 .5 19 .3-23 .7 4, 60 3, 89 8 4, 13 6, 23 7 5, 07 1, 55 8

C

I: con

fiden

ce i

nterv

al. D

R

C

: De

m

ocratic R

epu

blic o

f C

ongo. I

PT

p: in

ter

m

itte

nt prev

entive treat

m

ent in

pregn

an

cy

. Mai

nl: Mai

nla

nd

. P

: Prin

cipe.

*F

or s

ur

ve

ys

w

ith

a data s

et a

vailable, conf

iden

ce i

nterv

al

s h

av

e been

calc

ulated adj

us

ted f

or th

e clus

ter des

ig

n of

th

e s

urv

ey

. In

addition

, w

e ev

alu

ate

d th

e dif

fe

re

nce i

n sta

ndard er

ror betw

ee

n

poin

t prev

alen

ce of

IPT

p w

he

n adj

us

tm

en

t f

or clu

steri

ng

w

as

con

du

cted (eT

able 3

.1).

F

or

su

rv

ey

s f

or

w

hic

h w

e did n

ot

ha

ve

a dat

as

et,

w

e adj

us

ted the s

tan

dard error u

sin

g t

his

es

ti

m

ate, an

d

us

ed this

to calcu

la

te th

e conf

id

en

ce in

ter

vals

adj

us

ted f

or clu

steri

ng

. For Gu

in

ea B

iss

au

, no sa

m

ple size

w

as a

vailable, a

nd

w

e

us

ed t

he s

am

ple s

ize of

th

e prev

ious

su

rv

ey

in

2006 as

bes

t

es

ti

m

ate (n

=2506).

(16)

eTable 6.

2: Calculation of nu

m

b

er of births covered by in

secticide-treated nets

and antenatal ca

re in s

ub-Saharan Africa, projected fo

r 20

10

Co untr y Ma la ri a ex po sed Liv e + s till-bi rths 2010 * Co unt ries wit h IT N su rv ey ‘0 9-11 Ma la ri a ex po se d bi rths i n 2010 in co untr ie s wit h I T N su rv ey 20 09 -1 1 IT N use (% ) 95% C I† Nu m be r of ma la ria ex po se d bi rths pr ot ec te d by I T N for 2010 Lo we r 95% C I bi rths pr ote cte d Uppe r 95% C I bi rths pr ote cte d ANC s ur ve y ye ar Ma la ri a ex po sed bi rths i n 2010 in cou nt ries w ith ANC da ta ANC cov era ge , •Y LVLW  95% C I ‡, % Nu m be r of ma la ria ex po se d bi rths cov ered b y ANC, •  vi si t, fo r 2010 Lo we r 95% C I bi rth cov ered U pp er 95% C I bi rths pr ote cte d A ng ol a 78 5, 370 1 78 5, 370 25 .6 21 .7-29 .5 20 1, 055 17 0, 425 23 1, 684 20 11 78 5, 370 75 .1 71 .0-79 .2 58 9, 813 55 7. 613 62 2, 013 Be ni n 34 6, 457 1 34 6, 457 75 .5 72 .9-78 .1 26 1, 575 25 2, 567 27 0, 538 20 11 -1 2 34 6, 457 85 .8 84 .3-87 .3 29 7, 260 29 1. 064 30 2, 457 Bo ts w ana 25 ,4 80 Bur ki na F as o 69 0, 187 1 69 0, 187 44 .5 41 .4-47 .6 30 7, 133 28 5, 737 32 8, 529 20 10 -1 1 69 0, 187 94 .9 94 .1-95 .7 65 4, 987 64 9, 466 66 0, 509 Bur un di 19 6, 205 1 19 6, 205 49 .9 46 .0-53 .8 97 ,9 06 90 ,2 54 10 5, 558 20 10 -1 1 19 6, 205 98 .9 98 .6-99 .2 19 4, 046 19 3, 458 19 4, 635 Cam ero on 69 7, 536 1 69 7, 536 19 .8 16 .6-23 .0 13 8, 112 11 5, 791 16 0, 433 20 11 69 7, 536 84 .7 83 .1-86 .3 59 0. 813 57 9, 65 3 60 1, 97 4 CA R 15 4,3 94 20 06 15 4, 394 69 .3 67 .1-71 .5 10 6, 995 10 3, 598 11 0, 392 Ch ad 49 8, 687 1 49 8, 687 9. 9 8. 3-11. 5 49 ,3 70 41 ,3 91 57 ,3 49 20 10 49 8, 687 42 .6 40 .6-44 .6 21 2, 441 20 2, 467 22 2, 414 Co m or os 26 ,9 52 Co ng o 13 9, 98 4 1 13 9, 98 4 20 .7 17 .9-23 .5 28 ,9 77 25 ,0 57 32 ,8 96 20 11 -1 2 13 9. 98 4 92 .6 91 .1-94 .1 12 9, 62 5 12 7, 52 5 13 2, 72 5 Co te d' Ivo ire 68 3, 221 1 68 3, 221 39 .9 36 .6-43 .2 27 2, 605 25 0, 059 29 5, 151 20 11 -1 2 68 3, 221 90 .6 89 .0-92 .2 61 8, 998 60 8, 066 62 9, 929 D jibo uti 16 ,8 79 1 16 ,8 79 25 .2 17 .9-32 .5 4, 25 3 3, 02 1 5, 48 6 20 08 -9 16 ,8 79 80 .6 78 .1-83 .1 13 ,6 04 13 ,1 82 14 ,0 26 D R C 2, 69 0, 154 1 2, 69 0, 154 42 .6 39 .8-45 .4 1, 14 6, 006 1, 07 0, 681 1, 22 1, 330 20 10 2, 69 0, 154 87 .3 85 .6-89 .0 2, 34 8, 504 2. 30 2, 772 2, 39 4, 23 7 Eq uato rial G uine a 24 ,4 67 1 24 ,4 67 35 .4 30 .4-40 .4 8, 66 1 7, 43 8 9, 88 5 20 09 24 ,4 67 97 .1 94 .9-99 .3 23 ,7 57 23 ,2 19 24 ,2 95 E ritr ea 16 6, 932 20 04 16 6, 932 78 .2 72 .0-84 .4 13 0, 541 12 0, 191 14 0, 981 E th io pia 1, 72 1, 769 1 1, 72 1, 769 34 .7 29 .5-39 .9 59 7, 454 50 7, 922 68 6, 986 20 10 -1 1 1, 72 1, 769 33 .9 32 .1-35 .7 58 3, 680 55 2, 688 61 4, 672 Ga bo n 39 ,7 27 20 08 39 ,7 27 89 .1 87 .3-90 .9 35 ,3 97 34 ,6 82 36 ,1 12 G am bia 65 ,8 19 1 65 ,8 19 26 .1 23 .5-28 .7 17 ,1 79 15 ,4 67 18 ,8 90 20 10 65 ,8 19 98 .1 96 .9-99 .3 64 ,5 68 63 ,7 78 65 ,3 58 Gh an a 76 9,2 92 20 08 76 9, 292 95 .4 93 .8-97 .0 73 3, 905 72 1, 596 74 6, 214 G uine a 39 1, 313 20 07 39 1, 313 88 .4 86 .9-89 .9 34 5, 920 34 0, 051 35 1, 790 G uine a B is sa u 59 ,0 83 1 59 ,0 83 31 .7 27 .9-35 .5 18 ,7 29 16 ,4 84 20 ,9 74 20 10 59 .0 83 93 .0 91 .2-94 .8 54 ,9 47 53 ,8 83 56 ,0 10 K eny a 1, 07 4, 013 1 1, 07 4, 013 41 .1 35 .8-46 .4 44 1, 419 38 4, 497 49 8, 342 20 10 1, 07 401 3 85 .8 83 .7-87 .9 92 1. 503 89 8, 949 94 4, 058 L ibe ria 14 9, 70 9 1 14 9, 70 9 39 .0 33 .8-44 .2 58 ,3 87 50 ,6 02 66 ,1 71 20 11 14 9, 70 9 95 .2 93 .2-97 .2 14 2, 52 3 13 9, 52 9 14 5, 51 7 Ma dag as car 64 9, 095 1 64 9, 095 71 .5 66 .2-76 .8 46 4, 103 42 9, 701 49 8, 505 20 11 64 9, 095 82 .8 79 .6-86 .0 53 7, 451 51 6, 680 55 8, 222 Mal aw i 63 5, 128 1 63 5, 128 35 .2 33 .0-37 .4 22 3, 565 20 9, 592 23 7, 538 20 10 63 5, 128 94 .7 93 .9-95 .5 60 1, 466 59 6, 385 60 6, 547

21

8

Referenties

GERELATEERDE DOCUMENTEN

Keywords: mediolateral balance control; prosthetic walking; prototype; hip strategy; asymmetric lateral trunk

Assessment of satisfaction with cancer care: development, cross-cultural psychometric analysis and application of a comprehensive instrument..

If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of

If you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of

We investigated in a double blind randomised trial, firstly, whether symptoms disappeared after injection with corticosteroids proximal to the carpal tunnel and, secondly, how

Notwithstanding the inconclusiveness of the organic relationship with domestic courts 100 , or the paucity of its statutory relationship with them 101 , the Court did take notice

Please Ask the Library: https://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will

Canadezen, Europeanen en afgevaardigden van de VS die dit verdrag en TTIP voor ogen hebben, koersen niet alleen op onder- linge vrijhandel, maar op wereldwijde standaarden